Record No:1
ACCESS NO | D106485 |
GENE_NAME | CDKN2D |
DESCRIPTION | Cyclin dependent kinase inhibitor 2D |
ALIASES | INK4D, p19, p19-INK4D. |
NCBI_ENTREZ_NO | 1032 |
UNIPROT_ACCESS_NO | P55273 |
ORGANISM | Human |
DISEASE_PHENOTYPE | Childhood Asthma |
SAMPLE | Peripheral Blood Mononuclear Cells (PBMCs) |
TECHNIQUES | RNA Sequencing |
OMICS | Transcriptomics |
STUDY | High Throughput |
GEO_PRIDE_ACCESS_NO | GSE96783 |
COMMENTS | CDKN2D was up regulated in asthmatics as compared to healthy controls. |
REFERENCE | 29518416 |
IMMUNITY_TERM | No |
GO_MOLECULAR_FUNCTION | Cyclin-dependent protein serine/threonine kinase inhibitor activity, protein binding, kinase activity, protein kinase binding. |
GO_BIOLOGICAL_PROCESS | Regulation of cyclin-dependent protein serine/threonine kinase activity, G1/S transition of mitotic cell cycle, DNA synthesis involved in DNA repair, cell cycle, cell cycle arrest, sensory perception of sound, negative regulation of cell proliferation, response to UV, phosphorylation, negative regulation of cell growth, response to retinoic acid, response to vitamin D, negative regulation of phosphorylation, negative regulation of cysteine-type endopeptidase activity involved in apoptotic process, negative regulation of cyclin-dependent protein serine/threonine kinase activity, autophagic cell death, negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage, negative regulation of cell cycle G1/S phase transition, negative regulation of G1/S transition of mitotic cell cycle. |
BIOGRID_INTERACTION_ID | 107466 |
SNP_ID | - |
DRUG_ID | - |
STRUCTURE_ID | 209651 209652 |
MONOCLONAL_ANTIBODY | - |